Amr El-Refaey: EU Market Share of Biosimilars Approved in Oncology Indications

Amr El-Refaey, Medical Affairs and New Therapy Areas Lead at the Globalpharma LLC, shared a post on LinkedIn:

“EU Market Share of Biosimilars Biosimilars Oncology Indications as a share of the total market!

Click, Zoom and Enjoy!”